SCHEMBL5223370

SCHEMBL5223370

COc1ccc(NC=O)c(C=O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 3/20 0.56
ALDH1A1 P00352 8/20 0.53
TRIM24 O15164 1/20 0.51
TYR P14679 1/20 0.51
TRIM33 Q9UPN9 1/20 0.51
OR51E2 Q9H255 1/20 0.48
CYP1A2 P05177 5/20 0.45
CYP2C19 P33261 2/20 0.45
KDM4E B2RXH2 2/20 0.45
MAPT P10636 1/20 0.45
CYP2A6 P11509 1/20 0.42
LMNA P02545 1/20 0.41
CYP2C9 P11712 1/20 0.41
RAB9A P51151 1/20 0.41
HTT P42858 1/20 0.41
CYP1A1 P04798 3/20 0.40
CYP1B1 Q16678 3/20 0.40
F10 P00742 1/20 0.39
JUN P05412 1/20 0.39
NFKB1 P19838 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30996639 0.86 ALDH1A1 (0.58) ERN1ALDH1A1TRIM24TYRTRIM33
SCHEMBL28504582 0.84 ERN1 (0.58) ERN1ALDH1A1TRIM24TYRTRIM33
SCHEMBL13323847 0.81 ERN1 (0.47) ERN1ALDH1A1TRIM24TYRTRIM33
SCHEMBL2203559 0.80 ALDH1A1 (0.56) ALDH1A1OR51E2CYP1A2MAPTLMNA
SCHEMBL5597294 0.80 GAA (0.53) ERN1ALDH1A1TRIM24TYRTRIM33
SCHEMBL31432473 0.79 TRIM24 (0.56) ERN1ALDH1A1TRIM24TYRTRIM33
SCHEMBL2095308 0.79 OR51E2 (0.48) ERN1ALDH1A1OR51E2CYP1A2MAPT
SCHEMBL30505740 0.78 ERN1 (0.51) ERN1ALDH1A1TRIM24TYRTRIM33
SCHEMBL1161802 0.78 ERN1 (0.56) ERN1ALDH1A1TRIM24TYRTRIM33
SCHEMBL29951677 0.78 ERN1 (0.56) ERN1ALDH1A1TRIM24TYRTRIM33

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1456197-B1 PIPERIDINE-2,6-DIONES THAT ARE HETEROCYCLICALLY SUBSTITUTED IN POSITION 3 GRUENENTHAL GMBH (DE) 2007-02-28 EP disclosed
US-7183274-B2 Piperidine-2,6-diones heterocyclically substituted in the 3-position GRUENENTHAL GMBH (DE) 2007-02-27 US disclosed
US-20050020581-A1 Piperidine-2,6-diones heterocyclically substituted in the 3-position GRUENENTHAL GMBH (DE) 2005-01-27 US disclosed
EP-1456197-A1 PIPERIDINE-2,6-DIONES THAT ARE HETEROCYCLICALLY SUBSTITUTED IN POSITION 3 Grünenthal GmbH (DE) 2004-09-15 EP disclosed
WO-2003053956-A1 PIPERIDINE-2,6-DIONES THAT ARE HETEROCYCLICALLY SUBSTITUTED IN POSITION 3 Grünenthal GmbH (DE) 2003-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050020581-A1 Piperidine-2,6-diones heterocyclically substituted in the 3-position DPYD, CYP2D6, DHPS ERN1 3571/4885ALDH1A1 128/4885TRIM24 4774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.